Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Buyer beware for SARS-CoV-2 antibody detection

Sep. 30, 2020

Aligos receives CTA clearance to begin first-in-human study of ALG-000184 for hepatitis B

Sep. 29, 2020

FDA places partial clinical hold on planned phase II/III trial of INO-4800

Sep. 29, 2020

FDA approves Fetroja for the treatment of HABP and VABP

Sep. 29, 2020

FSD Pharma initiates phase II study of FSD-201 in hospitalized patients with COVID-19

Sep. 29, 2020

Medicines for Malaria Venture begins phase I study of MMV-688533

Sep. 29, 2020

FDA clears IND for phase II study of Stemedica's itMSCs for COVID-19

Sep. 28, 2020

Novavax initiates U.K. phase III study of NVX-CoV2373 COVID-19 vaccine candidate

Sep. 28, 2020

Janssen's COVID-19 vaccine candidate JNJ-78436735 enters phase III

Sep. 25, 2020

Japanese phase III study of Avigan shows promise in patients with COVID-19

Sep. 25, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...